$5.09
1.55% day before yesterday
Nasdaq, Dec 27, 10:01 pm CET
ISIN
US68401U2042
Symbol
OPRX

OptimizeRx Corporation Stock price

$5.09
-0.24 4.50% 1M
-5.23 50.68% 6M
-9.22 64.43% YTD
-9.01 63.90% 1Y
-58.26 91.97% 3Y
-4.98 49.45% 5Y
+1.88 58.57% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.08 1.55%
ISIN
US68401U2042
Symbol
OPRX
Industry

Key metrics

Market capitalization $93.76m
Enterprise Value $113.35m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.29
P/S ratio (TTM) P/S ratio 1.06
P/B ratio (TTM) P/B ratio 0.82
Revenue growth (TTM) Revenue growth 40.40%
Revenue (TTM) Revenue $88.18m
EBIT (operating result TTM) EBIT $-7.57m
Free Cash Flow (TTM) Free Cash Flow $-1.67m
Cash position $16.13m
EPS (TTM) EPS $-1.33
P/E forward negative
P/S forward 1.04
EV/Sales forward 1.26
Short interest 6.22%
Show more

Is OptimizeRx Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

OptimizeRx Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a OptimizeRx Corporation forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a OptimizeRx Corporation forecast:

Buy
88%
Hold
13%

Financial data from OptimizeRx Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
88 88
40% 40%
100%
- Direct Costs 37 37
35% 35%
42%
51 51
44% 44%
58%
- Selling and Administrative Expenses 54 54
9% 9%
62%
- Research and Development Expense - -
-
-
-3.33 -3.33
77% 77%
-4%
- Depreciation and Amortization 4.24 4.24
129% 129%
5%
EBIT (Operating Income) EBIT -7.57 -7.57
54% 54%
-9%
Net Profit -24 -24
76% 76%
-27%

In millions USD.

Don't miss a Thing! We will send you all news about OptimizeRx Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OptimizeRx Corporation Stock News

Neutral
GlobeNewsWire
6 days ago
WALTHAM, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that William J. Febbo, Chief Executive Officer (CEO) and Board Member, will be departing the Company, effective as of December 31, 20...
Neutral
GlobeNewsWire
about one month ago
WALTHAM, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
Neutral
Seeking Alpha
about 2 months ago
OptimizeRx Corporation (NASDAQ:OPRX ) Q3 2024 Results Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants William Febbo - Chief Executive Officer Edward Stelmakh - Chief Financial Officer and Chief Operational Officer Steve Silvestro - President Conference Call Participants Ryan Daniels - William Blair & Company, LLC Sean Dodge - RBC Capital Markets Kyle Bauser - B. Riley...
More OptimizeRx Corporation News

Company Profile

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.

Head office United States
CEO Will Febbo
Employees 136
Founded 1985
Website www.optimizerx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today